• Create first-in-class products for the pharmaceutical industry

  • Bypass resistance by focusing treatments on patients

  • Use a common mechanism to treat multiple infectious diseases
 
   
   
     
  Inhibikase Therapeutics focuses on innovation. The Company strives to cut the development time to proof-of-concept by more than half, potentially bringing product to market in as little as five years from initiation of the research and development effort.  

 

 

 

 

 

Content on this page requires a newer version of Adobe Flash Player.

Get Adobe Flash player

Inhibikase looks at infectious disease differently. The Company creates products that target the patient, not the pathogen. This approach blocks a virus (or a bacterium) from reproducing in the patient and stimulates the patient's immune system to fight future infections without administration of more of the Company product. Thus, Inhibikase's treatments treat the disease and prevent reoccurrence, improving overall health for patients. Several of the Company's products have the potential to fight multiple diseases simultaneously, like flu and pneumonia, smallpox and PML and they may enhance success of kidney and other organ transplants.

A key advantage of the Inhibikase approach is the focus on the patient. Blocking a common pathway in the patient avoids creating resistance to the Company's products. If fully realized, Inhibikase could actually create permanent solutions to common ailments that affect the every day lives of people. Our goal is a school year without colds or ear infections, flu or strep throat and vacations for relaxation, not convalescence.

 

Inhibikase is developing preventative and curative treatments for infectious diseases that affect more than 100 million patients worldwide. Products under development include treatments for:

 

Content on this page requires a newer version of Adobe Flash Player.

Get Adobe Flash player

Get Involved!

Follow our blog, tweets and visit us on Facebook

Contribute

Make a difference and contribute a sawbuck.

 

Terms of Use Privacy Policy
Website Maintenance by inConcert Web Solutions | Site Map
 
Respiratory Infectious Disease Biodefense Respiratory Disease Influenza Diarrhrea Home Page Email